Publications by authors named "Peter J Wild"

100Publications

A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade.

Urol Oncol 2020 06 18;38(6):603.e1-603.e7. Epub 2020 Feb 18.

Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada; Department of Surgical Oncology, Division of Urology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Department of Surgery, Division of Urology, Mount Sinai Hospital, Toronto, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2020.01.007DOI Listing
June 2020

[Importance of tumour mutation burden testing].

Authors:
Peter J Wild

Pathologe 2019 Dec;40(Suppl 3):366-368

Dr. Senckenbergisches Institut für Pathologie, Universitätsklinikum Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Deutschland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00292-019-00717-3DOI Listing
December 2019

Multi-laboratory proficiency testing of clinical cancer genomic profiling by next-generation sequencing.

Pathol Res Pract 2018 Jul 22;214(7):957-963. Epub 2018 May 22.

Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091, Zurich, Switzerland; Senckenberg Institute of Pathology, University Hospital Frankfurt, 60590, Frankfurt, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prp.2018.05.020DOI Listing
July 2018

Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer.

Oncotarget 2018 Feb 4;9(12):10284-10293. Epub 2017 Dec 4.

Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.22888DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828186PMC
February 2018

Aberrant methylated key genes of methyl group metabolism within the molecular etiology of urothelial carcinogenesis.

Sci Rep 2018 02 22;8(1):3477. Epub 2018 Feb 22.

Epigenetics Core Laboratory, Institute of Transplantation Diagnostics and Cell Therapeutics, Medical Faculty, Heinrich-Heine University Duesseldorf, Moorenstr. 5, 40225, Duesseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-018-21932-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823913PMC
February 2018

Detecting circulating tumor DNA in renal cancer: An open challenge.

Exp Mol Pathol 2017 04 23;102(2):255-261. Epub 2017 Feb 23.

Institute of Surgical Pathology, University Hospital Zurich, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexmp.2017.02.009DOI Listing
April 2017

TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer.

Cancer Cell 2016 06 26;29(6):846-858. Epub 2016 May 26.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2016.04.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124371PMC
June 2016

Combined deletion of Vhl, Trp53 and Kif3a causes cystic and neoplastic renal lesions.

J Pathol 2016 07 30;239(3):365-73. Epub 2016 May 30.

Institute of Physiology, University of Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.4736DOI Listing
July 2016

Clinical impact of prostate biopsy undergrading in an academic and community setting.

World J Urol 2016 Oct 1;34(10):1481-90. Epub 2016 Mar 1.

Department of Urology, University Hospital Zurich, University of Zurich, Frauenklinikstr.10, 8091, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-016-1788-4DOI Listing
October 2016

Formation of Renal Cysts and Tumors in Vhl/Trp53-Deficient Mice Requires HIF1α and HIF2α.

Cancer Res 2016 04 12;76(7):2025-36. Epub 2016 Jan 12.

Institute of Physiology, University of Zurich, Zurich, Switzerland. Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-1859DOI Listing
April 2016

Combined Deletion of Vhl and Kif3a Accelerates Renal Cyst Formation.

J Am Soc Nephrol 2015 Nov 18;26(11):2778-88. Epub 2015 Mar 18.

Institute of Physiology and Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland; and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1681/ASN.2014090875DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625677PMC
November 2015

Dosimetry and first clinical evaluation of the new 18F-radiolabeled bombesin analogue BAY 864367 in patients with prostate cancer.

J Nucl Med 2015 Mar 12;56(3):372-8. Epub 2015 Feb 12.

Division of Nuclear Medicine, Department of Medical Radiology, University Hospital of Zurich, Zurich, Switzerland Division of Medical Oncology, Department of Internal Medicine, University Hospital of Zurich, Zurich, Switzerland

View Article

Download full-text PDF

Source
http://jnm.snmjournals.org/cgi/doi/10.2967/jnumed.114.147116
Publisher Site
http://dx.doi.org/10.2967/jnumed.114.147116DOI Listing
March 2015

In cystectomy specimens with bladder cancer whole organ embedding increases the detection rate of histopathological parameters, but not of those with prognostic significance.

Virchows Arch 2015 Apr 13;466(4):423-32. Epub 2015 Feb 13.

Institute of Pathology, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-015-1726-7DOI Listing
April 2015

Prognostic significance of POLE proofreading mutations in endometrial cancer.

J Natl Cancer Inst 2015 Jan 12;107(1):402. Epub 2014 Dec 12.

Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (DNC, IPMT); Oxford Cancer Centre, Churchill Hospital, Oxford, UK (DNC); Department of Pathology (ES, NtH, VTHBMS, TB) and Department of Clinical Oncology (RAN, CLC), Leiden University Medical Center, Leiden, the Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland (NV, AN, PJW); Vesalius Research Center (VRC), VIB, Leuven, Belgium (JD, DL); Laboratory of Translational Genetics, Department of Oncology, KU Leuven, Belgium (FA, DL); Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, University Hospitals Gasthuisberg, Leuven, Belgium (FA); Genomic Medicine Theme, Oxford Comprehensive Biomedical Research Centre, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (IPMT); Department of Radiation Oncology, University Medical Centrum Utrecht, the Netherlands (IMJS); Department of Radiation Oncology, Medisch Spectrum Twente, Enschede, the Netherlands (JJJ).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju402DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301706PMC
January 2015

Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy.

Clin Cancer Res 2014 Apr;20(8):2169-81

Authors' Affiliations: Departments of Molecular Medicine and Urology and Institute of Pathology, Aarhus University Hospital, Aarhus, Denmark; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Department of Urology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany; Institute of Biomedical Technology and BioMediTech, University of Tampere and Tampere University Hospital, Tampere, Finland; Departments of Oncology and Pathology and Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-13-2642DOI Listing
April 2014

SPOP mutations in prostate cancer across demographically diverse patient cohorts.

Neoplasia 2014 Jan;16(1):14-20

Department of Pathology and Laboratory Medicine, Institute of Precision Medicine, Weill Medical College of Cornell University, New York, NY ; Department of Urology, Weill Medical College of Cornell University, New York, NY ; Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924544PMC
http://dx.doi.org/10.1593/neo.131704DOI Listing
January 2014

Ultra-deep sequencing confirms immunohistochemistry as a highly sensitive and specific method for detecting BRAF V600E mutations in colorectal carcinoma.

Virchows Arch 2013 Nov 2;463(5):623-31. Epub 2013 Oct 2.

Institute of Surgical Pathology, University Hospital Zurich, Schmelzbergstrasse 12, 8091, Zurich, Switzerland,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-013-1492-3DOI Listing
November 2013

TMARKER: A free software toolkit for histopathological cell counting and staining estimation.

J Pathol Inform 2013 30;4(Suppl):S2. Epub 2013 Mar 30.

Institute for Computational Science, ETH Zurich, Switzerland ; Competence Center for Systems Physiology and Metabolic Diseases, ETH Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/2153-3539.109804DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678753PMC
June 2013

Expression of serotonin receptors in human hepatocellular cancer.

Clin Cancer Res 2012 Nov 19;18(21):5902-10. Epub 2012 Oct 19.

Departments of Surgery and Pathology, Swiss Hepato-Pancreato-Biliary Center, University Hospital Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-1813DOI Listing
November 2012

Intrafascial dissection significantly increases positive surgical margin and biochemical recurrence rates after robotic-assisted radical prostatectomy.

Urol Int 2012 27;89(1):17-24. Epub 2012 Jun 27.

Department of Urology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000339254DOI Listing
December 2012

Profiling gastrin-releasing peptide receptor in prostate tissues: clinical implications and molecular correlates.

Prostate 2012 Feb 7;72(3):318-25. Epub 2011 Jul 7.

Institute of Clinical Pathology, University Hospital of Zürich, Zürich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.21434DOI Listing
February 2012

Serine threonine kinase 15 amplification in normal urothelium of cystectomy specimens is no prognostic factor in urothelial carcinoma of the bladder.

Pathol Res Pract 2011 Mar 17;207(3):161-3. Epub 2011 Jan 17.

Department of Urology, University of Regensburg, Caritas St. Josef Medical Centre, Landshuterstraße 65, 93053 Regensburg, Germany.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S034403381000291
Publisher Site
http://dx.doi.org/10.1016/j.prp.2010.12.006DOI Listing
March 2011

Infinite mixture-of-experts model for sparse survival regression with application to breast cancer.

BMC Bioinformatics 2010 Oct 26;11 Suppl 8:S8. Epub 2010 Oct 26.

Department of Computer Science, University of Basel, Bernoullistr, 16, CH-4056 Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2105-11-S8-S8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2966295PMC
October 2010

Low frequency of epigenetic events in urothelial tumors in young patients.

J Urol 2010 Aug 17;184(2):459-63. Epub 2010 Jun 17.

Academic Urology Unit and Institute for Cancer Studies, University of Sheffield, Sheffield, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2010.03.131DOI Listing
August 2010

Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma.

Eur Urol 2009 Oct 7;56(4):636-43. Epub 2009 Jul 7.

Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2009.06.036DOI Listing
October 2009

Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer.

BMC Cancer 2009 Jul 1;9:217. Epub 2009 Jul 1.

Molecular Oncology Group, Institute of Pathology, University Hospital of the RWTH Aachen, Pauwelsstrasse 30, D-52074 Aachen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-9-217DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717119PMC
July 2009

Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma.

Clin Cancer Res 2009 May 28;15(10):3297-304. Epub 2009 Apr 28.

Department of Pathology, Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-2779DOI Listing
May 2009

Computational pathology analysis of tissue microarrays predicts survival of renal clear cell carcinoma patients.

Med Image Comput Comput Assist Interv 2008 ;11(Pt 2):1-8

Institute for Computational Science, ETH Zürich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-540-85990-1_1DOI Listing
December 2008

HER3 is a determinant for poor prognosis in melanoma.

Clin Cancer Res 2008 Aug;14(16):5188-97

Department of Molecular Biology, Max-Planck Institute of Biochemistry, Munich, Germany.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-08-0186DOI Listing
August 2008